EUVIMEDEUVIMED entdecken
Crossref

La relación entre el índice de respuesta a la inflamación sistémica y las características clínicas e hitopatológicas en el cáncer gástrico

Hikmet Pehlevan-Özel, Tolga Dinç, Nermin D Okay, Mesut Tez

Cirugía y Cirujanos · 2025

DOI: 10.24875/ciru.23000234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cirugía y Cirujanos, 2025. Verfasst von Hikmet Pehlevan-Özel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Mamak State Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Systemic Inflammatory Response Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The systemic inflammation response index (SIRI) is a marker used to predict survival. The aim of this study is to examine the relationship between SIRI and clinicopathological features and survival.

Method

The relationship between clinicopathological characteristics and survey and SIRI was retrospectively investigated.

Results

A total of 178 patients were included in the study. Poor prognostic factors such as tumor size, t, T-stage, tumor-node-metastasis (TNM) stage, and CA19-9 level were found to have a statistically significant relationship with patients with high SIRI (p = 0.039, p = 0.001, p = 0.001 and p = 0.013, respectively). A high SIRI was found to be an independent and poor prognostic factor for 3-year and 5-year survival (p = 0.014 and p = 0.027, respectively).

Conclusions

High SIRI was associated with a poor survival rate, as were advanced TNM stage, advanced T stage, larger tumor size, and elevated CA19-9 level; all these are poor prognostic markers for gastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaSystemic Inflammatory Response SyndromeHumansFemaleMaleRetrospective StudiesMiddle AgedAgedPrognosisNeoplasm StagingAdultCA-19-9 AntigenAged, 80 and overSurvival RateLymphatic MetastasisInflammation

Stichwörter der Autor:innen

Clinical featuresGastric adenocancerSystemic inflammation response index

Substanzen

CA-19-9 Antigen

Autor:innen und Institutionen

  • Department of Surgery, Mamak State Hospital, Ankara, Turkey.
  • Department of General Surgery, School of Medicine, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
  • Department of Surgery, General Surgery Clinic, Ankara City Hospital, Ankara, Turkey.

Zitieren

APA

Pehlevan-Özel, H., Dinç, T., Okay, N. D., & Tez, M. (2025). La relación entre el índice de respuesta a la inflamación sistémica y las características clínicas e hitopatológicas en el cáncer gástrico. Cirugía y Cirujanos. https://doi.org/10.24875/ciru.23000234

Vancouver

Pehlevan-Özel H, Dinç T, Okay ND, Tez M. La relación entre el índice de respuesta a la inflamación sistémica y las características clínicas e hitopatológicas en el cáncer gástrico. Cirugía y Cirujanos. 2025. doi:10.24875/ciru.23000234

BibTeX
@article{Pehlevanzel2025,
  author = {Pehlevan-Özel, Hikmet and Dinç, Tolga and Okay, Nermin D and Tez, Mesut},
  title = {La relación entre el índice de respuesta a la inflamación sistémica y las características clínicas e hitopatológicas en el cáncer gástrico},
  journal = {Cirugía y Cirujanos},
  year = {2025},
  doi = {10.24875/ciru.23000234}
}
Kostenlos starten →